Terbutaline

This page shows anti-doping rule violation data we have registered for Terbutaline.

Number of cases in Terbutaline Last 10 Years

Terbutaline

Terbutaline ranks #45 globally among prohibited substances, with 80 registered cases (0.5% of all violations) among all sports tracked by the Anti-Doping Database, which contains 14,670 verified cases. India leads with 17 cases, while Track and field is the most affected sport (13 cases).

Cases of Terbutaline by Sport
Track and field
13
Cycling
12
Swimming
7
Tennis
4
Cricket
4
Top Sport: Track and field

13

Track and field cases

0%

Of all violations

80

Total Terbutaline cases
Track and field's share of Terbutaline violations 0%
13 of 80

Track and field has the most recorded cases of Terbutaline violations globally, with 13 registered cases — 0% of all 80 verified cases.

Cases of Terbutaline by Country
India
17
France
9
Sweden
9
Spain
7
United Kingdom
5
Top Country: India

17

India cases

21.3%

Of all violations

80

Total Terbutaline cases
India's share of Terbutaline violations 21.3%
17 of 80

India leads significantly in Terbutaline violations globally, with 17 registered cases — 21.3% of all 80 verified cases.

Global Substance Ranking

Terbutaline ranks #45 of 358 prohibited substances in the Anti-Doping Database.

#1 Stanozolol
1,359
#2 Methandienone
833
#3 Norandrosterone
778
#4 Testosterone
758
···
#45 Terbutaline
80
About This Ranking

This ranking covers only prohibited substances with verified case records in the Anti-Doping Database. Procedural violations (whereabouts failures, refusals to test, etc.) are excluded.

Active Sanctions — Expiry Year
Gender Distribution
Male 80%
64 cases
Female 20%
16 cases
Analysis: 's gender distribution (80% male, 20% female) aligns closely with the global average. Global average: 80.2% male, 19.8% female
Average Suspension Length
13.1
months
Terbutaline
30.1
months
Global average

The average suspension for Terbutaline violations is 13.1 months, shorter than the global average of 30.1 months.

Terbutaline is permitted by use of inhalers only to prevent and/or treat asthma and exercise induced asthma. The relevant medical authority must be informed of their use prior to competition. This substance was first listed in the IOC doping list in 1988 as a permitted beta-2 agonist by inhalation only. It has remained under conditional use regulations.

If you use this data, please credit The Anti-Doping Database

The intelligence tool for anti-doping professionals

Used by journalists, sport lawyers, NADOs and researchers worldwide for proactive strategy — not just post-case research.

 

As a subscriber you get instant access to verified, structured anti-doping case data — from hours of research to seconds:

  • Complete athlete and sanction details
    • Identity, ban periods, substances used, test type, violation information and more.
  • Verified documents and case materials
    • Access sanction decisions, PDFs and official sources when available.
  • Advanced insights and historical trends
    • Statistics across sports, countries, substances and year-by-year comparisons — for proactive planning, not just post-case analysis.

The Anti-Doping Database currently contains 14,670 verified anti-doping rule violations across all sports and all countries, and is updated regularly.